Waseet Vance
Radiation Oncology · Fleming Island, FLNPI 1477703031
Payments from drug & device makers
Across 71 payments — averaging $76.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Elekta, Inc.$4K
- Brainlab, Inc.$566
- GT Medical Technologies, Inc$413
- Novartis$134
- Foundation Medicine, Inc.$89
- Daiichi Sankyo Inc.$80
- plus $636 from 28 others
What the payments were for
- Travel & lodging$3,28761%
- Food & beverage$2,13339%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Elekta, Inc. | 6 | $3,501 |
| Brainlab, Inc. | 6 | $566 |
| GT Medical Technologies, Inc | 3 | $413 |
| Novartis | 10 | $134 |
| Foundation Medicine, Inc. | 1 | $89 |
| Daiichi Sankyo Inc. | 4 | $80 |
| Siemens Medical Solutions USA, Inc. | 4 | $78 |
| Sanofi | 5 | $63 |
| Visionrt, Inc. | 1 | $61 |
| Astellas Pharma US Inc | 3 | $37 |
| Incyte Corporation | 3 | $35 |
| Beigene USA, Inc. | 2 | $29 |
| Octapharma USA, Inc. | 2 | $25 |
| Immunocore Limited | 1 | $24 |
| Accuray Incorporated | 1 | $23 |
| Boehringer Ingelheim | 1 | $21 |
| Clovis Oncology, Inc. | 1 | $20 |
| Merck | 1 | $17 |
| Exelixis Inc. | 1 | $16 |
| AVEO Pharmaceuticals, Inc. | 1 | $15 |
| AbbVie | 1 | $14 |
| Ipsen Biopharmaceuticals, Inc | 1 | $14 |
| Acceleron Pharma, Inc. | 1 | $14 |
| Springworks Therapeutics, Inc. | 1 | $14 |
| CSL Behring | 1 | $13 |
| Eisai Inc. | 1 | $13 |
| Aurobindo Pharma USA, Inc. | 1 | $13 |
| Stemline Therapeutics Inc. | 1 | $13 |
| Pfizer | 1 | $12 |
| Genentech USA, Inc. | 1 | $12 |
| Sanofi-aventis U.S. LLC | 1 | $12 |
| Johnson & Johnson | 1 | $11 |
| Bayer | 1 | $10 |
| United Imaging Healthcare North America, Inc. | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,420 in reported general payments places this provider in the 75th percentile of 465 radiation oncology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron OdtOndansetron | 20 | $369 |
| Oxycodone Hcl | 16 | $335 |
| Morphine Sulfate ErMorphine Sulfate | 11 | $316 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 19 | $184 |
| Famotidine | 19 | $136 |
| Lorazepam | 31 | $28 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Fleming Island
- Charles KunosMiami$3.2M
- Rupesh KotechaMiami$2M
- Alexander EngelmanTampa$1.1M
- John SylvesterLakewood Ranch$999K
- Kamran AhmedTampa$975K
- Michael ChuongMiami$868K
- Tithi BiswasGainesville$640K
- Daniel TrifilettiJacksonville$606K
- Marcus BredelMiami$578K
- Kathryn HitchcockGainesville$504K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.